Trial lawyers in Michigan continue to agitate for repeal of the law, which, uniquely among the 50 states, affords manufacturers a defense in product liability actions for pharmaceuticals marketed in compliance with FDA regulation. At the Manhattan Institute (with which I’m associated), a new report from the Trial Lawyers Inc. project defends the law (“The Move to Reverse Michigan’s Model Reforms”, June). Also see Point of Law, Apr. 11.
Michigan drug liability law
Trial lawyers in Michigan continue to agitate for repeal of the law, which, uniquely among the 50 states, affords manufacturers a defense in product liability actions for pharmaceuticals marketed in compliance with FDA regulation. At the Manhattan Institute (with which I’m associated), a new report from the Trial Lawyers Inc. project defends the law (“The […]
Comments are closed.